Veristat is a clinical research organization (CRO) that specializes in delivering innovative solutions for the development and commercialization of life-changing therapies. With 29 years of experience in clinical trial planning and execution, Veristat collaborates with clients to overcome unique and complex challenges associated with drug development. They have supported the approval of groundbreaking therapies, including the first gene therapy approved in Europe.

Veristat's expertise spans across clinical development, regulatory approval, and post-marketing stages, offering flexible engagement models and customized development plans for success. They provide full-service, functional service, and resourcing/FSP solutions, ensuring milestones are met on budget and on time. Veristat is renowned for its unparalleled regulatory experience and commitment to compliance.

They are dedicated to partnering with emerging, small, and mid-size biopharmaceutical companies, guiding them through study design complexities and achieving positive results. With a passionate team, Veristat strives to make a difference by bringing therapies to market and improving lives